Alvina Dewi Astuty (2020) Cost Of Illness Pada Pasien Diabetes Melitus Dengan Diabetic Foot : Systematic Review. Skripsi thesis, UNIVERSITAS AIRLANGGA.

	Text 1. HALAMAN JUDUL.pdf Download (921kB)
	Text 2. ABSTRACT.pdf Download (164kB)
	Text 3. DAFTAR ISI.pdf Download (191kB)
	Text 4. BAB I PENDAHULUAN.pdf Download (184kB)
	Text 5. BAB II TINJAUAN PUSTAKA.pdf Restricted to Registered users only until 7 June 2024. Download (646kB) | Request a copy
	Text 6. BAB III KERANGKA KONSEPTUAL.pdf Restricted to Registered users only until 7 June 2024. Download (272kB) | Request a copy
	Text 7. BAB IV METODE PENELITIAN.pdf Restricted to Registered users only until 7 June 2024. Download (322kB) | Request a copy
	Text 8. BAB V HASIL DAN PEMBAHASAN.pdf Restricted to Registered users only until 7 June 2024. Download (588kB) | Request a copy
	Text 9. BAB VI KESIMPULAN DAN SARAN.pdf Restricted to Registered users only until 7 June 2024. Download (60kB) | Request a copy
	Text 10. DAFTAR PUSTAKA.pdf Download (291kB)
	Text 11. LAMPIRAN.pdf Restricted to Registered users only until 7 June 2024. Download (531kB) | Request a copy
	Text KKC KK FF.Kom.17-21-Embargo_C_051611133092_Alvina Dewi Astuty - alvina dewi.pdf Restricted to Registered users only Download (147kB) | Request a copy

Abstract

Diabetes mellitus (DM) is one of the leading causes of death from non-communicable disease in the world. Diabetes can cause further complications if the patient does not comply with the therapy given, one of them is diabetic foot. DM with diabetic foot complication brings huge economic losses. This study aims to determine the cost of illness in DM patients with diabetic foot. This research using PRISMA guideline which was conducted in April – July 202. The search for articles was searched on the Pubmed, Cochrane, Sciencedirect, Scopus, and Ebscohost using PICO to determine the keywords. From the seven articles that were included in this study, it was found that the total costs generated varied from 2341,63 USD/year to 20977,56 USD/year for patient perpective, 2703,24 USD/year to 8790,41 USD/year and 8129,96 USD/episode for hospital perpective, and 2144,21 USD/episode and 14819,78 USD/year for perpective third payer. The majority of research uses retrospective and hospital perspective. The most calculated costs are direct medical costs with costs reaching 51.7% to 98.4% of the total costs incurred for the treatment. Meanwhile, the cost spent on treatment for DM patients with diabetic foot is two to four times greater than DM patients without diabetic foot with the percentage of costs for complications of diabetic foot alone reaching 55.9% to 71.7% of the total costs incurred. Thus, the results of this research can become one of the considerations for policy makers to make policies that can reduce the burden of medical costs.

Actions (login required)

View Item